Core Viewpoint - The company is strategically investing in Suzhou Changhe Biotechnology Co., Ltd. to acquire a 57.14% stake, aiming to expand its business in the field of biosafety monitoring [2]. Group 1: Investment Strategy - The investment is based on the company's strategic development plan and is a cautious decision to enhance its market position in biosafety monitoring [2]. - The acquisition will allow for deep integration in product technology development, operational production, and sales channels between the company and Changhe Biotechnology [2]. Group 2: Market Position and Product Development - The company is a leading player in the gas sensor industry, with a strong market position in indoor and outdoor air quality sensors, including PM2.5, CO2, VOC, and formaldehyde sensors [2]. - The strategic integration with Changhe Biotechnology will enable the company to expand its sensor industry into high-end biosafety detection instruments [2]. - The company plans to leverage its core component advantages in the sensor field to develop low-cost biosafety sensors for mass applications in home appliances, automotive, and building sectors [2].
四方光电:2026年1月,公司以自有资金受让出资额并增资的方式取得苏州畅合生物科技有限公司57.14%的股权